Search

everythinglearnresearchcommunity

for

Search:↓

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

The mutated hairless gene causes hair loss by acting as a new type of corepressor affecting thyroid hormone receptors.

LH and hCG reduce certain protein levels in women's skin.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

TRH stimulates human hair growth and extends the hair growth phase.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Both cyproterone acetate and spironolactone effectively reduce hair growth in women with hirsutism.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Spironolactone can reduce hair growth in women with hirsutism.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

CRH promotes fat production in skin cells, affecting conditions like acne.

Spironolactone effectively reduces unwanted hair growth in women with hirsutism.

Adrenocorticotropic hormone inhibits growth and affects body composition in male rats.

Blocking certain brain processes reduces mating behavior in female rats.

Oral contraceptives and antiandrogens are the best treatments for hirsutism.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.